Advertising
The use of medical cannabis is an area of great interest for both general practitioners and patients and is an area of extensive ongoing research and legislative evolution.
Clinical
Medicinal cannabis is generally well tolerated, but the science related to its potential adverse effects is in its infancy.
There is a great deal of interest in the potential symptomatic benefits of medicinal cannabis for developmental disorders.
Patients and physicians need to be aware of the important implications that medical cannabis use may have for driving.
It is unlikely that medicinal cannabis will be used as a first-line agent for the management of pain, nausea and other specific symptoms, but it may have a complementary role within palliative care.
Editorial
Letters
Readers express their opinions on published articles and topics of interest.
Dry eye disease is often underappreciated and underdiagnosed due to the vague nature of the symptoms.
Case Study
A woman aged 62 years had a telehealth appointment for the management of osteoporosis.
A man aged 79 years who was living in a residential aged care facility and had an indwelling urinary catheter was noted by the caregiver to have ‘purple urine’ for more than a week.
In this article, the authors describe a method for marking a lesion for excision.
Research
General practice registrars are responsible for a significant proportion of immunisations in Australian older adults.
Although nutrition is important to bone health, the impact of different dietary patterns on bone density and fracture is unclear.
When integrated into general practice, non-dispensing pharmacists provide clinical services within a team-based model of care to improve patient outcomes and quality use of medications.
Asthma presentations are common in general practice, but opportunities to control asthma are often missed.
Transgender people may seek healthcare for reasons unrelated to gender, but they are often negatively impacted by structural and interpersonal discrimination in health settings.
While clinical guidelines recommend increasing the use of long-acting reversible contraceptives, current contraceptive use and management in Australia do not reflect these recommendations.
General practitioners’ ability to promptly recognise potentially serious side effects of treatment, especially those unique to newer therapies, can be crucial to patient safety.
Clinical challenge
This clinical challenge is based on this month’s Focus articles. To complete this activity, go to the RACGP website.